- Home
- ZURA vs SMLR Comparison
ZURA vs SMLR Comparison
Compare ZURA & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- SMLR
- Stock Information
- Founded
- ZURA 2022
- SMLR 2007
- Country
- ZURA United States
- SMLR United States
- Employees
- ZURA N/A
- SMLR N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZURA Health Care
- SMLR Health Care
- Exchange
- ZURA Nasdaq
- SMLR Nasdaq
- Market Cap
- ZURA 292.1M
- SMLR 289.5M
- IPO Year
- ZURA N/A
- SMLR 2014
- Fundamental
- Price
- ZURA $2.80
- SMLR $58.55
- Analyst Decision
- ZURA Buy
- SMLR
- Analyst Count
- ZURA 6
- SMLR 0
- Target Price
- ZURA $15.80
- SMLR N/A
- AVG Volume (30 Days)
- ZURA 363.2K
- SMLR 1.1M
- Earning Date
- ZURA 11-07-2024
- SMLR 11-04-2024
- Dividend Yield
- ZURA N/A
- SMLR N/A
- EPS Growth
- ZURA N/A
- SMLR N/A
- EPS
- ZURA N/A
- SMLR 2.04
- Revenue
- ZURA N/A
- SMLR $58,938,000.00
- Revenue This Year
- ZURA N/A
- SMLR N/A
- Revenue Next Year
- ZURA N/A
- SMLR N/A
- P/E Ratio
- ZURA N/A
- SMLR $31.11
- Revenue Growth
- ZURA N/A
- SMLR N/A
- 52 Week Low
- ZURA $2.00
- SMLR $20.88
- 52 Week High
- ZURA $6.35
- SMLR $79.45
- Technical
- Relative Strength Index (RSI)
- ZURA 33.79
- SMLR 58.51
- Support Level
- ZURA $2.71
- SMLR $56.75
- Resistance Level
- ZURA $2.87
- SMLR $63.29
- Average True Range (ATR)
- ZURA 0.26
- SMLR 8.95
- MACD
- ZURA -0.03
- SMLR -0.19
- Stochastic Oscillator
- ZURA 13.77
- SMLR 42.40
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.